RevBio

Lowell, MA · Founded 2014 · Privately Held (backing)

Developer of regenerative adhesive biomaterial, designed to facilitate bone repair and regeneration in medical procedures. RevBio is based in Lowell, MA and was founded in 2014. It has raised $45.8 million across 2 recorded rounds; the latest was a $10 million early-stage round in Apr 2023.

Last price · $/share
—
Implied valuation
—
Total raised
$45.8M
Last round
Early Stage VC
Apr 2023
How much has RevBio raised?
$45.8Macross 2 recorded rounds · Jun 2021 – Apr 2023

Most recently, RevBio raised $10.0M in its Early Stage VC (Apr 2023).

Free account
More of RevBio with a free account
  • ·The complete investor list: 18 names
  • ·Watch RevBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

RevBio round by round

2 rounds
Apr 2023Early Stage VC$10.0MSEC filing▮
54 investors participated
Jun 2021Early Stage VC$9.0MSEC filing▮
34 investors participated

How much has RevBio raised?

RevBio has raised $45.8 million in total; 2 of its rounds are on record. The largest on record was a $9 million early-stage round in Jun 2021; the most recent was a $10 million early-stage round in Apr 2023.

RevBio has filed 5 Form Ds with the SEC since 2021, most recently in Jul 2025 ($10 million sold to 54 investors).

RevBio investors

18 investors are on record for RevBio, including MassChallenge, MedTech Innovator, The JHA Capital and Beacon Angels. The early-stage round in Apr 2023 drew 54 investors.

For fundraisers
Raising for a company like RevBio?

18 investors have backed RevBio.

See all 18 investors →

Frequently asked about RevBio

How much has RevBio raised?
RevBio has raised $45.8M in total across 2 recorded funding rounds.
When was RevBio's last funding round?
RevBio's most recent recorded round was Early Stage VC in Apr 2023, raising $10.0M.